Xianghong Jasmine Zhou
Vorstandsvorsitzender bei EarlyDiagnostics, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Wenyuan Li | M | - |
EarlyDiagnostics, Inc.
 EarlyDiagnostics, Inc. Packaged SoftwareTechnology Services EarlyDiagnostics, Inc. is a company that specializes in developing a blood test called CancerRadar, which is highly accurate and sensitive in detecting and locating cancer. The company is based in Los Angeles, CA. The company offers experimental and computational innovations such as CFSNV, a novel computational tool to accurately call mutations directly from blood, and EarlyDX-Cloud, a "one-stop shop" bioinformatics solution for liquid biopsy. The company was founded in 2017 by Wing H. Wong, Wenyuan Li, Xianghong Jasmine Zhou. Xianghong Jasmine Zhou has been the CEO since 2017. | 7 Jahre |
| Gregory Critchfield | M | 72 |
EarlyDiagnostics, Inc.
EarlyDiagnostics, Inc. Packaged SoftwareTechnology Services EarlyDiagnostics, Inc. is a company that specializes in developing a blood test called CancerRadar, which is highly accurate and sensitive in detecting and locating cancer. The company is based in Los Angeles, CA. The company offers experimental and computational innovations such as CFSNV, a novel computational tool to accurately call mutations directly from blood, and EarlyDX-Cloud, a "one-stop shop" bioinformatics solution for liquid biopsy. The company was founded in 2017 by Wing H. Wong, Wenyuan Li, Xianghong Jasmine Zhou. Xianghong Jasmine Zhou has been the CEO since 2017. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Wing H. Wong | M | - |
EarlyDiagnostics, Inc.
EarlyDiagnostics, Inc. Packaged SoftwareTechnology Services EarlyDiagnostics, Inc. is a company that specializes in developing a blood test called CancerRadar, which is highly accurate and sensitive in detecting and locating cancer. The company is based in Los Angeles, CA. The company offers experimental and computational innovations such as CFSNV, a novel computational tool to accurately call mutations directly from blood, and EarlyDX-Cloud, a "one-stop shop" bioinformatics solution for liquid biopsy. The company was founded in 2017 by Wing H. Wong, Wenyuan Li, Xianghong Jasmine Zhou. Xianghong Jasmine Zhou has been the CEO since 2017. | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 3 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Xianghong Jasmine Zhou
- Persönliches Netzwerk
